regulator

How To Use regulator In A Sentence

• A couple of examples from my own experience at FDA with the review of biopharmaceuticals will illustrate the tension between the regulatory culture and innovation.
• Still, for the medium term, either the government needs to scutinize refinery activity much more closely, adopt new regulatory authority and aggressively enforce antitrust laws, or it must intervene to deconcentrate the market. Robert Weissman: What To Do About the Price of Oil
• The invention concerns a cable drum having a non-cylindrical profile of its outer surface and the use of this cable drum in a window regulator system, particularly in a vehicle.
• The work of regulatory agencies was also undermined by budget cuts and a concerted unwillingness to enforce existing regulations.
• Relations with the regulatory agencies are coordinated by the Chief Financial Officer.
• The watchdog plans to issue formal regulatory guidance setting out how companies should handle endowment complaints and assess where compensation is due.
• Objective To study the effects of retinoic acid on the differentiation of human rhabdomyosarcoma cells and on the expression of myogenic regulatory factor (MRF).
• Most staff being laid off worked on the factory floor, assembling the thermostats and power regulators.
• It will deliver the promises made in the citizens charter to extend the powers of the four regulators of the privatised utilities.
• Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Somaxon's business, including, without limitation, Somaxon's interpretation of its communications and interactions with the FDA relating to the requirements for approval of the NDA for Silenor, and the FDA's agreement with such interpretation; Somaxon's interpretation of the results of the clinical trials for Silenor, the timing of the interpretation of such results and the FDA's agreement with such interpretation; the potential for Somaxon to make a resubmission to the Silenor NDA; the potential for Silenor to receive regulatory approval for one or more indications on a timely basis or at all; the potential for the FDA to impose non-clinical, clinical or other requirements to be completed before or after regulatory approval of Silenor; Somaxon's ability to demonstrate to the satisfaction of the FDA that potential NDA approval of Silenor is appropriate prior to the completion of standard, long-term carcinogenicity studies, given the context of completed trials and pending studies; the timing and results of non-clinical studies for Silenor, and the FDA's agreement with Somaxon's interpretation of such results; Digital50.com Digital 50 Daily Industry News RSS Feed